The Kentucky Life Sciences Council applauds the House and Senate for passing long‑overdue pharmacy benefit manager (PBM) reforms, an important step toward curbing the opaque and anticompetitive practices of healthcare middlemen whose profit‑driven models have burdened patients, employers, and taxpayers for far too long. 

KLSC urges Congress to advance the government funding package containing practical PBM reforms that address the affordability crisis fueled by the unfair and profit‑driven practices of healthcare middlemen. 

As we celebrate the holiday season, KLSC is making its list and checking it twice...and every ask represents a critical step toward better care and innovation. Now it’s up to Congress to deliver these legislative gifts that will bring real cheer to patients and providers. The groundwork has been laid, the momentum is strong, and it’s time to push these measures across the finish line. 

The Kentucky Life Sciences Council commends Senators Mike Crapo (R-ID) and Ron Wyden (D-OR) for their leadership in advancing federal PBM reform with the introduction of the PBM Price Transparency and Accountability Act.

The bioscience industry footprint is growing in Kentucky, as a new report shows the bioscience workforce in the Commonwealth employs 17,341 people, an increase of 11 percent over the past 5 years.

Around the world, millions of patients, suffering from cancer, Alzheimer’s, cystic fibrosis, and many other chronic diseases, are holding onto hope that one day soon there will be a cure—and America’s biopharmaceutical companies are dedicated to turning these hopes into reality.